DB18421InvestigationalGene Therapies
tgAAG-76 consists of a recombinant adeno-associated virus (serotype 2) (rAAV2) gene transfer agent expressing RPE65.
- Also known as
- rAAV2/2.hRPE65p.hRPE65
- Code names
- tgAAG-76
What you can answer from here — as of April 02, 2025
Which companies are running trials of tgAAG-76, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account